Best Targeted Therapy Treatment Hospitals Worldwide

Apollo Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The JCI accredited hospital was established in 1983 in Chennai, India and has 550 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

Fortis Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The NABH, NABL accredited hospital was established in 2004 in Noida, India and has 400 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

The state-of-the-art Targeted Therapy services offered by Medical Park Gebze Hospital, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Kocaeli, Turkey. Founded in 2015, the JCI accredited hospital has 120 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.

At Manipal Hospital, Dwarka, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The NABH accredited facility has been functioning since 2018 and is located in Delhi, India. The hospital has 380 beds and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

At Guven Hospital, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The GHA accredited facility has been functioning since 1975 and is located in Ankara, Turkey. The hospital has 254 beds and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

At Vinmec Phu Quoc Hospital, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The JCI accredited facility has been functioning since 2015 and is located in Phu Quoc, Vietnam. The hospital has 150 beds and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

The state-of-the-art Targeted Therapy services offered by Vinmec Times City, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Ha noi, Vietnam. Founded in 2012, the JCI accredited hospital has 500 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.

At Casa di Cura La Madonnina, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The SSN accredited facility has been functioning since 1958 and is located in milan, Italy. The hospital has 560 beds and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

With advanced oncology infrastructure, Fortis Hospital offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2001, the NABH, NABL, JCI accredited hospital is located in Bangalore, India, and has 375 beds.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.

At Sarvodaya Hospital and Research Centre, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The NABH, NABL accredited facility has been functioning since 1997 and is located in Faridabad, India. The hospital has 500 beds and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

At Medstar Antalya Hospital, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The JCI accredited facility has been functioning since 2009 and is located in Ankara, Turkey. The hospital has 124 beds and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

The state-of-the-art Targeted Therapy services offered by Vinmec Smart City Hospital, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Ha noi, Vietnam. Founded in 2020, the JCI accredited hospital has 500 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.

OncoCare Cancer Centre aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The NABH accredited hospital was established in 2020 in Amroha, India and it has adequate bed capacity to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

At Vinmec Da Nang, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 2017, the JCI accredited hospital is located in Da Nang, Vietnam, and has 222 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.

Vinmec Nha Trang aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The JCI accredited hospital was established in 2017 in Nha Trang, Vietnam and has 150 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.